Roche

Big pharma’s key second-quarter data
EP Vantage
Tue, 03/29/22 - 10:32 am
Roche
tiragolumab
Giredestrant
Sanofi
Eli Lilly
tirzepatide
Novo Nordisk
GSK
Pfizer
RSV
Big Pharma has skirted long Covid, but a pipeline of small biotechs are testing treatments for lingering symptoms
Endpoints
Sun, 03/27/22 - 03:58 pm
COVID-19
Long COVID
GSK
Vir Biotechnology
Humanigen
Pfizer
Roche
Atea Pharmaceuticals
Roche comes up short in its attempt to hold off generic competition to Esbriet
Endpoints
Thu, 03/24/22 - 08:38 pm
Roche
Esbriet
IPF
generics
Merck fights back against Roche in adjuvant lung cancer therapy
Pharmaforum
Fri, 03/18/22 - 10:54 am
Merck
Keytruda
non-small cell lung cancer
clinical trials
Roche
Tecentriq
JHL's Judas Kiss: an Inside Look at JHL Biotech's Theft from Genentech
BioSpace
Fri, 03/18/22 - 10:44 am
JHL Biotech
Genentech
Roche
trade secrets
Rituxan
After Alexion buyout, AstraZeneca pays Roche $775M to settle Ultomiris patent brawl
Fierce Pharma
Thu, 03/17/22 - 10:38 am
AstraZeneca
Roche
Chugai
Ultomiris
patents
Aiming to drug genetic modifiers, Roche-partnered biotech bags $31M to fuel a drive toward clinic
Endpoints
Thu, 03/10/22 - 10:27 am
Scenic Biotech
Roche
Genentech
genetic modifiers
A trio of amyloid-targeted Alzheimer's drugs will soon see key results, but an analyst predicts only 50-50 odds for one
Endpoints
Wed, 03/9/22 - 11:09 pm
Alzheimer's disease
clinical trials
Roche
Eli Lilly
Biogen
donanemab
lecanemab
gantenerumab
Sanofi, scarred by Roche scrap, hits goal in once-weekly hemophilia A trial and plots race to regulators
Fierce Biotech
Wed, 03/9/22 - 10:54 am
Sanofi
Roche
Sobi
hemophilia A
clinical trials
Roche starts new four-year trial of Alzheimer’s drug gantenerumab
Pharmaforum
Fri, 03/4/22 - 09:48 am
Roche
Alzheimer's disease
clinical trials
gantenerumab
BMS, Novartis, Akebia and more face FDA approval decisions soon, with big sales on the line
Fierce Pharma
Thu, 03/3/22 - 10:33 am
FDA
drug approvals
FibroGen
AstraZeneca
daprodustat
Bristol Myers Squibb
Opdivo
Roche
tiragolumab
Merck
favezelima
bInnovent
Eli Lilly
Akeso Biopharma
Sino Biopharmaceutical
Novartis
Ukoniq
TG Therapeutics
GW Pharmaceuticals
Marinus Pharmaceuticals
Roche steps up with a free supply of antibiotics for Ukraine as drug donations begin to flow
Endpoints
Wed, 03/2/22 - 10:06 pm
Roche
Ukraine
Rocephin
Roche's Foundation Medicine gets FDA breakthrough device nod in latest designations
Medtech Dive
Mon, 02/28/22 - 09:34 am
Roche
Foundation Medicine
diagnostics
tumor DNA
breakthrough designations
Medtech
Roche's gene therapy unit finds a new Spark as co-founding CEO makes way for new leader
Fierce Biotech
Wed, 02/23/22 - 10:28 pm
Roche
gene therapy
Spark Therapeutics
Jeffrey D. Marrazzo
Ron Philip
Roche and AstraZeneca settle years long patent battle over Ultomiris — report
Endpoints
Sun, 02/20/22 - 11:48 am
Roche
Chugai
AstraZeneca
Alexion
patents
Ultomiris
Soliris
Covid infects biopharma’s biggest sellers
EP Vantage
Thu, 02/17/22 - 10:45 am
Pfizer
AstraZeneca
vaccines
COVID-19
Roche
Roche-backed biotech refuels with $40M to steer neuromuscular candidate toward late-stage trials
Endpoints
Tue, 02/15/22 - 10:27 am
NMD Pharma
Roche
neuromuscular disease
funding
Eli Lilly and Roche ask CMS not to be lumped in with Aduhelm’s restrictive judgment
Endpoints
Mon, 02/14/22 - 11:06 am
Eli Lilly
Roche
Biogen
Alzheimer's disease
Aduhelm
CMS
The biggest launches of 2022: a reboot
EP Vantage
Mon, 02/14/22 - 10:48 am
drug launches
Eli Lilly
tirzepatide
Alnylam
vutrisiran
Roche
Vabysmo
JNJ
Carvykti
Mirati Therapeutics
adagrasib
Bristol Myers Squibb
mavacamten
deucravacitinib
Vas Narasimhan and Severin Schwan each claimed pay packets worth $12M+ for 2021
Endpoints
Sat, 02/12/22 - 11:49 pm
Roche
Novartis
executive pay
Severin Schwan
Vas Narasimhan

Pages